Numerous putative heat shock protein 90 (Hsp90)-interacting proteins, which could represent novel folding clients or cochaperones, have been identified in recent years. Two separate high-throughput screens in yeast uncovered genetic effects between Hsp90 and components of the ER membrane complex (EMC), which is required for tolerance to unfolded protein response stress in yeast. Herein, we provide the first experimental evidence supporting that there is a genuine interaction of Hsp90 with the EMC. We demonstrate genetic interactions between EMC2 and the known Hsp90 co-chaperone encoded by STI1, as well as Hsp90 point mutant allele-specific differences in inherent growth and Hsp90 inhibitor tolerance in the absence and presence of EMC2. In co-precipitation experiments, Hsp90 interacts with Emc2p, whether or not Emc2p contains amino acid sequences designated as a tetratricopeptide repeat motif. Yeast with multiple EMC gene deletions exhibit increased sensitivity to Hsp90 inhibitor as well as defective folding of the well-established Hsp90 folding client, the glucocorticoid receptor. Altogether, our evidence of physical, genetic, and functional interaction of Hsp90 with the EMC, as well as bioinformatic analysis of shared interactors, supports that there is a legitimate interaction between them in vivo.
Introduction
The heat shock protein 90 (Hsp90) molecular chaperone is a ubiquitous, abundant, and essential component of eukaryotic cells (Schopf et al. 2017) . Hsp90, in collaboration with a host of co-chaperones, plays important roles not only in the Bhousekeeping^functions of cells under normal conditions, but it is also further upregulated under conditions of cellular stress affecting the stability of its folding Bclients.^First noted for its participation in the folding and activation of a small number of client proteins, namely steroid hormone receptors and kinases, the folding and functional repertoire of Hsp90 has vastly expanded in the past decade and a half. This is due in large part to high-throughput, in some cases genomewide, approaches in Saccharomyces cerevisiae aimed at further defining its scope of cellular functions and interactors (Gong et al. 2009; Gopinath et al. 2014; McClellan et al. 2007; Millson et al. 2005; Zhao et al. 2005 ). An in-depth understanding of Hsp90's cellular activities is increasingly important in light of the fact that Hsp90, by virtue of enabling the activity of oncogenic versions of its folding clients, is being investigated as a tractable target for therapeutic intervention in cancers (Chatterjee and Burns 2017; Jhaveri et al. 2012 ). Hsp90 and its co-chaperones are also culpable in the replication of viral proteins critical for infectivity and are meaningfully implicated in neurogenerative disorders, particularly tauopathies (Dickey et al. 2007; Geller et al. 2012; Geller et al. 2007; Luo et al. 2007; Pratt and Toft 2003; Shelton et al. 2017; Wang et al. 2017) .
At present, from the results of both targeted experimental and high-throughput approaches, there are 1789 unique S. cerevisiae Hsp90 interactors curated in the online database BioGRID (Stark et al. 2006) , which has served as one public resource used toward building a complete picture of Hsp90 interactions in the cell (Echeverria et al. 2011) . These interactors may represent not only folding clients but also co-chaperone proteins that regulate and define the mechanism and client interactions of Hsp90 (Cox and Johnson 2018; Eckl and Richter 2013) . While Hsp90 co-chaperones interact with Electronic supplementary material The online version of this article (https://doi.org/10.1007/s12192-018-0908-z) contains supplementary material, which is available to authorized users. different regions of Hsp90 utilizing various types of protein motifs, one of the most common interaction domains shared by Hsp90 co-chaperones is comprised of the tetratricopeptide repeat (TPR) motif; co-chaperones that interact via their TPR domain bind to highly conserved residues at the extreme Cterminus of Hsp90 (MEEVD) (Scheufler et al. 2000) .
Two different genome-wide screens in yeast identified the open reading frame YJR088C as a potential Hsp90 interactor (McClellan et al. 2007; Zhao et al. 2005) . This is of interest as YJR088C is predicted to contain TPRs, suggesting that it could be a novel Hsp90 co-chaperone. Subsequently, this ORF was named EMC2 when it was identified as a member of the evolutionarily conserved ER membrane complex (EMC) whose components contribute to the successful tolerance of ER stress, namely the unfolded protein response (UPR) (Jonikas et al. 2009 ). While the essential cellular roles of the EMC have remained somewhat elusive, in yeast, it has been linked not only to ER stress, but it has also been predicted to act as a tethering complex that facilitates the transfer of ER-synthesized phospholipids to mitochondria (Lahiri et al. 2014) . In mammalian cells, EMC components have been connected to autophagy (Li et al. 2013; Shen et al. 2016) , shown to protect against West Nile virus-induced cell death (Ma et al. 2015) , and most recently, demonstrated to facilitate the insertion of newly synthesized transmembrane domain-bearing proteins into the ER membrane (Guna et al. 2018 ). The latter is in keeping with the EMC's occurrence in the genetic network that attends to a misfolded ABC transporter in yeast and from work in Caenorhabditis elegans, in which the EMC assists the synthesis of acetylcholine receptors (Louie et al. 2012; Richard et al. 2013) .
Herein, we investigate whether the occurrence of EMC2 as a putative interaction partner of Hsp90 is borne out by experimental validation. In addition, as two other members of the EMC, EMC5 and EMC6, were also enriched in Hsp90 target screens (McClellan et al. 2007) , we extend our analysis to the larger EMC. Our findings demonstrate genetic, physical, and functional interactions between Hsp90 and the EMC, suggesting that there is indeed a bona fide relationship between them in cells.
Materials and methods
Yeast media, manipulations, strains, and plasmids Standard yeast media recipes for rich growth medium (YPD), synthetic complete (SC), and synthetic complete dropout media (e.g., SC-Ura) were followed (Adams 1997) . Standard lithium acetate transformation was used to introduce plasmids into yeast (Adams 1997) .
Strains herein referred to as WT90, G170D, E381K, T101I, and G313S were derived from a W303 background and have the following genotype: MATa ade2-1 leu2-3,112 his3-11,15 trp1-1 ura3-1 can1-100 hsc82::LEU2 hsp82::LEU2 HIS3::GPD-HSP82 (WT90) or hsp82 G170D , hsp82 E381K , hsp82
T101I
, and hsp82 G313S (Nathan and Lindquist 1995) . All other strains are BY4743 diploid (MATa/α his3Δ1/his3Δ1 l e u 2 Δ 0 / l e u 2 Δ 0 LYS2/lys2Δ 0 met15Δ 0 / M E T 1 5 ura3Δ0/ura3Δ0) or BY4741 haploid (MATa his3Δ1/his3Δ1 l e u 2 Δ 0 / l e u 2 Δ 0 LYS2/lys2Δ 0 met15Δ 0 / M E T 1 5 ura3Δ0/ura3Δ0) strains from the yeast deletion collection, with singly deleted genes replaced by the KANMX4 cassette (Giaever 2002) . The multiple EMC deletion strains (Lahiri et al. 2014 ) are in BY4741 with the following specific modifications: YSL4 (emc1::HIS5 emc5::kanMX4), YSL5 (emc3::HIS5 emc6::KanMX4), YSL6 (emc1::HIS5 emc2::hygMX4 emc5::kanMX4), YSL9 (emc1::HIS5 emc2::hygMX4 emc3::HIS5 emc5::kanMX4 emc6::kanMX4), YSL27 (emc1::HIS5 emc2::hygMX4 emc3::HIS5 emc6::kanMX4), and YSL57 (emc2::hygMX4 emc5::kanMX4 emc6::kanMX4) and were kindly provided by William Prinz (Cell and Molecular Biology, NIDDK, NIH).
To generate the Δemc2Δsti1 double-deletion strain, the following primer pair was used to amplify the HIS3 gene and append the STI1 sequences (lowercase) to both ends:
The purified PCR fragment was introduced to BY4741 Δemc2 yeast using standard lithium acetate transformation and recovery in YPD prior to being plated on selective media (SC-HIS) and incubated at 30°C for several days. Resulting colonies were screened further to confirm successful homologous recombination via PCR using primers internal to the STI1 gene and by immunoblotting protein extracts with antiSti1p antisera.
To delete EMC2 in WT and mutant Hsp90 strains, the following primer pair was used to amplify the kanamycin resistance cassette from pFA6a-3xHA-kanMX6 (Longtine et al. 1998 ) and append the EMC2 sequences (lowercase) to both ends:
The purified PCR fragment was introduced to yeast using standard lithium acetate transformation and recovery in YPD prior to being plated on selective media (YPD + G418) and incubated at 30°C for several days. Resulting colonies were screened via PCR using primers internal to EMC2 to confirm successful deletion.
Molecular cloning
The following primer pair was used to amplify the EMC2 gene and append a BamHI site (underlined) and FLAG tag (MDYKDDDDK; coding sequence in bold) to the 5′ end and an XhoI site (underlined) to the 3′ end:
All subsequent cloning manipulations of EMC2 utilized BamHI and XhoI restriction sites in target vectors.
The following primers were used, in conjunction with the above primers, to amplify EMC2 sequences preceding and following the nucleotides encoding amino acids (first predicted TPR repeat motif):
5′ GCGAATTCATCAAGCGGGAATTT 3′ (used with BamHI primer above to amplify pre-TPR fragment; EcoRI site underlined) 5′ TTAGAATTCTACGCTTGTTTTGGTAGG 3′ (used with XhoI primer above to amplify post-TPR fragment; EcoRI site underlined)
The resulting PCR products were purified, digested with EcoRI and either BamHI (pre-TPR fragment) or XhoI (post-TPR fragment), and ligated in the presence of a cloning vector cleaved with BamHI and XhoI. The resulting emc2Δtpr sequence encodes a protein lacking endogenous amino acids 163-196, but with two introduced amino acids, a glutamic acid and a phenylalanine, between the pre-and post-TPR fragments (as a consequence of the EcoRI sequence in the primers). All subsequent cloning manipulations of emc2Δtpr utilized BamHI and XhoI restriction sites in target vectors.
Serial dilution growth assays
Yeast strains were inoculated into 2 mL of appropriate media and grown overnight in a 30°C shaking incubator. The next day, the optical density at 600 nm (OD 600 ) of each strain was determined with a Genesys™ 20 visible spectrophotometer (Thermo Scientific). Each strain was then diluted to an OD 600 of 0.01, from which subsequent tenfold dilutions were generated (0.001, 0.0001, and 0.0001). Five microliters of each dilution was spotted onto solid media. Plates were incubated at 30 or 37°C, as indicated, for 2-4 days.
Liquid growth curve assays
Yeast strains were inoculated into 2 mL of appropriate media and grown overnight in a 30°C shaking incubator. The next day, cultures were diluted to similar starting OD 600 values (0 .1) and loaded, in triplicate for each condition (no drug, 50 μM NVP-AUY922, or 150 μM NVP-AUY922) into a 96-well plate. The plate was incubated at either 30 or 37°C, as indicated in figure legends, with shaking, in a Tecan Infinite F200 plate reader (Tecan Group, Ltd.) . OD 595 readings were taken every 90 min for 12 h.
Affinity pulldowns
Yeast expressing histidine-tagged Hsp90 as the sole version of Hsp90 (GPD-Hsp82 FP ) (Chang and Lindquist 1994) were transformed with an empty vector, as well as with URA3-marked plasmids for the GPD-driven expression of Flagtagged full-length Emc2, emc2Δtpr, and His3 (intended as a negative control Flag-tagged protein; it expresses at similar level and is of comparable size). Positive transformants, confirmed by anti-Flag immunoblot, were grown overnight in a 30°C shaking incubator in 50 mL SC-Ura. Cells were harvested in mid/late log phase (OD 600 readings at the time of harvest ranged from 0.92 to 1.5), washed once with cold sterile water, and frozen in liquid nitrogen for storage at − 80°C. Subsequent affinity pulldowns were carried out essentially as described (Franzosa et al. 2011) , except using Flag agarose (Anti-FLAG M2 affinity gel; Sigma-Aldrich) in place of glutathione agarose. Total protein extracts and Flag agarosebound proteins were resolved by 12% SDS-PAGE, transferred to nitrocellulose, and analyzed with anti-(His) 6 antisera (to detect Hsp90) and anti-Flag antisera.
Beta-galactosidase assays
Yeast were co-transformed with plasmids (kindly provided by Jill Johnson, Department of Biological Sciences, University of Idaho) encoding mammalian glucocorticoid receptor (GR) and encoding beta-galactosidase under the transcriptional regulation of the glucocorticoid response element (GRE-lacZ). Induction of GR folding and subsequent beta-galactosidase assays were conducted as previously described (Liu et al. 1999) .
Results

EMC2 exhibits genetic interactions with the Hsp90 chaperone machinery
Three of the six components originally identified as the EMC in yeast (Jonikas et al. 2009 ) were identified as Hsp90 interactors in large-scale screens: EMC2, EMC5, and EMC6 (McClellan et al. 2007; Zhao et al. 2005) . We chose to focus our initial efforts on EMC2 for two reasons: first, EMC2 encodes the only soluble, cytoplasmic EMC protein, and second, EMC2 is predicted to encode a TPR domain, an interaction motif of both well-studied and emerging Hsp90 cochaperones (Cox and Johnson 2018; Eckl and Richter 2013) . The best established Hsp90 co-chaperone, Sti1p/p60/Hop, interacts with conserved residues in the extreme C-terminus of Hsp90 via its C-terminal TPR domain (Chen et al. 1996; . To investigate whether STI1 and EMC2 exhibit any genetic interaction, we created a Δsti1Δemc2 double-deletion strain to explore whether growth was exacerbated on media containing the Hsp90 inhibitor NVP-AUY922, herein referred to as NVP, which has previously been shown to be effective in yeast (Armstrong et al. 2012; Brough et al. 2008) . As shown in Fig. 1 , tested yeast strains were largely insensitive to NVP at 30°C but exhibited varying degrees of growth inhibition at 37°C (compare Fig. 1a to Fig. 1b) . While yeast lacking EMC2 grew similarly to wildtype (WT) yeast at the lower concentration of NVP (75 μM), Δemc2 yeast grew more poorly than WT at the higher concentration (200 μM); Δsti1 yeast exhibit temperature sensitivity at 37°C, even in the absence of NVP, and this growth defect is significantly exacerbated by NVP. Of note, the Δsti1Δemc2 double-deletion strain grew noticeably worse than Δsti1 both in the absence and presence of 75 μM NVP (Fig. 1b) . Neither strain grew at 37°C at the 200 μM concentration. The increased sensitivity of Δsti1Δemc2 yeast to NVP was also observed in liquid growth experiments conducted at 37°C (Fig. 1c) . Importantly, quantifiable and statistically significant growth rate differences (p < 0.001) between Δsti1 yeast or Δemc2 yeast and the Δsti1Δemc2 doubledeletion strain were observed even at a lower concentration of NVP than was utilized in the serial dilution experiments. Of note, there was also a significant difference (p < 0.01) in the doubling time of WT yeast and the Δsti1Δemc2 strain in the absence of Hsp90 inhibitor that was not observed between WT and either single deletion strain.
To explore whether the presence or absence of Emc2p generates detectable effects on the inherent or drug-challenged growth of Hsp90 mutant yeast, we next conducted growth experiments using yeast strains containing deletions of both endogenous copies of Hsp90 (HSP82 and HSC82) and expressing a single allele of either WT HSP82 (WT90) or various hsp82 point mutants (G170D, E381K, T101I, G313S) (Nathan and Lindquist 1995) . WT and mutant Hsp90 strains with and without the additional deletion of EMC2 were grown as triplicate samples in the absence or presence of increasing concentrations of the Hsp90 inhibitor NVP-AUY922. The results, shown in Fig. 2 , demonstrate obvious conditiondependent differences in the growth profiles. For example, while EMC2 deletion had little to no effect on WT90 yeast grown in the absence of drug, the G170DΔemc2 strain clearly exhibited slowed growth (compare Fig. 2a to Fig. 2b) . In other cases, such as in the presence of the lower concentration of NVP (50 μM), point mutant yeast lacking EMC2 demonstrated improved tolerance to Hsp90 inhibitor (compare T101I to T101IΔemc2; Fig. 2c, d ). These data are consistent with previous studies in which co-chaperones differentially affected the behavior of strains expressing Hsp90 alleles with point mutations in different structural domains of the protein (i.e., N-terminal nucleotide-binding domain, middle domain, or Cterminal dimerization domain), including having positive or negative effects on inherent viability as well as on Hsp90 inhibitor sensitivity (Armstrong et al. 2012; Flom et al. 2012; Johnson et al. 2007; Tenge et al. 2015) . Fig. 1 Yeast lacking STI1, EMC2, or both display increased sensitivity to Hsp90-inhibiting drug at 37°C. a Tenfold serial dilutions of BY4741 wild-type (WT) or deletion (Δ) strains on plates lacking (DMSO) or containing indicated concentrations of NVP-AUY922 (NVP); plates were incubated at 30°C for 2 days. b Same as a, except plates were incubated at 37°C for 2 days (DMSO only) or 3 days (NVPcontaining). c The indicated yeast strains were grown in liquid media for 12 h at 37°C in the absence or presence of 50 μM NVP. Data shown are mean ± standard deviation of triplicate samples. Statistically significant differences (p < 0.001) as determined by Student's t test are indicated with brackets and double asterisks (**). Additional statistically significant differences (p < 0.01) were found for the following pairwise comparisons: WT (0)/Δsti1Δemc2 (0), Δsti1 (0)/Δsti1Δemc2 (0), Δsti1Δemc2 (0)/Δsti1Δemc2 (50 μM), and Δemc2 (0)/Δsti1Δemc2 (0). A statistically significant difference (p < 0.05) was also observed between Δsti1 (0) and Δsti1 (50 μM)
The above experiments demonstrate a genetic interaction between EMC2 and an established Hsp90 co-chaperone (STI1), and between EMC2 and various Hsp90 alleles, but yield no information as to what the nature of that interaction may be. To address this, we next examined whether known Hsp90 co-chaperones with established roles as part of the Hsp90 machinery differentially affect the growth of yeast containing a single copy of HSP82 that do (WT90) or do not (WT90Δemc2) contain EMC2. Of the seven tested co-chaperones, only the expression of STI1 and TAH1 yielded differential results; while TAH1 expression permitted the growth of both HSP82 and HSP82Δemc2 strains at 37°C in the presence of NVP, STI1 expression rescued the ability of WT90 yeast to grow in the presence of NVP at 37°C only if EMC2 was present (Fig. 3) . This observation, with allele-specific variation, was also made with mutant Hsp90 strains containing or lacking EMC2. Specifically, we observe better growth rescue attributable to STI1 expression in G313S yeast only when EMC2 is present (Fig. 4a) , and while TAH1 expression assists both T101I and T101IΔemc2 growth in the presence of NVP, STI1 expression robustly rescues T101I growth, but not T101IΔemc2 growth, under the same conditions (Fig. 4b) . While TPR domain-containing co-chaperones such as Sti1p and Tah1p interact with the same region of Hsp90 (the extreme C-terminal amino acid MEEVD), they each facilitate interaction or scaffolding with different protein clients or complexes (see BDiscussion^). Our findings, therefore, indicate that there are likely to be both EMC2-dependent and EMC2-independent functions of Hsp90 in the cell. Furthermore, the data suggest that there is at least partial overlap between EMC2 dependence and STI1 dependence.
Collectively, these various growth experiments support that there is an authentic genetic interaction between EMC2 and the Hsp90 chaperone machinery in yeast, experimentally validating the identification of EMC2 as an Hsp90 interactor in multiple high-throughput screens (McClellan et al. 2007; Zhao et al. 2005) .
EMC2 physically interacts with Hsp90
We next tested whether Emc2p and Hsp90 physically interact. Numerous predictive algorithms were applied to the amino acid sequence of Emc2p in order to identify any sequence(s) likely to interact with Hsp90, specifically those predicted to be TPR motifs. While some programs, including ELM (Dinkel et al. 2016) and SMART (Letunic and Bork 2018) , identified no potential TPR motifs in EMC2p, InterPro (Finn et al. 2017) , PROSITE (Sigrist et al. 2013) , and CDD/SPARCLE (Marchler-Bauer et al. 2017 ) all predict Emc2p amino acids 163-196 as a TPR motif. We thus generated emc2Δtpr, which lacks the coding sequence for amino acids 163-196 and which no longer encodes any predicted conserved domains, TPR, or otherwise (Marchler-Bauer et al. 2017) . As shown in Fig. 5 , affinity isolation of Flag-tagged Emc2p (lane 3), but not of a control protein (Flag-His3p; lane 2), coisolated Hsp90. Of note, the deletion of the predicted TPR motif did not diminish the interaction of Emc2p with Hsp90 (lane 4). Thus, while this experiment supports that Hsp90 and Emc2p physically interact, it also suggests that a TPR domain, commonly found in Hsp90 co-chaperones, is not the means of interaction. Interestingly, while CDD/ SPARCLE no longer predicts any TPR motifs with the removal of amino acids , analysis of the fulllength EMC2 sequence predicts additional TPR motifs (amino acids 196-236 and 241-269), which could theoretically facilitate the interaction between Hsp90 and Emc2p. Of note, however, these additional putative TPR motifs were not identified by InterPro or PROSITE.
The EMC exhibits genetic and functional interactions with Hsp90
As mentioned above, other members of the EMC have been identified as Hsp90 interactors in high-throughput screens, namely EMC5 and EMC6 (McClellan et al. 2007; Zhao et al. 2005) . We thus extended our analysis from Emc2p to the larger EMC by utilizing yeast strains harboring deletions of multiple EMC components (Lahiri et al. 2014) . Δemc1Δemc2Δemc3Δemc5Δemc6) members of the EMC were first tested for sensitivity to NVP by serial dilution growth assay. While all of the strains tested were unaffected even by a high concentration of NVP at 30°C (200 μM), YSL9, YSL27, and YSL57 exhibited clear growth defects at 37°C in the presence of only 75 μM NVP (Fig. 6 ) and failed to grow at all in the presence of 200 μM NVP (data not shown).
We next tested whether the ability of Hsp90 to fold the well-established client protein GR was affected by EMC component deletion. As expected, WT yeast robustly fold GR while sti1Δ yeast exhibit severely compromised GR folding (Fig. 7) (Chang et al. 1997) . Furthermore, two of the multiple EMC deletion strains, YSL9 and YSL27, lacking five or four components of the EMC, respectively, were severely hampered with regard to GR folding (p < 0.001). Of note, however, the conditional expression of exogenous (v-src) or endogenous (Ste11p) kinases, which is toxic to yeast in an Hsp90-dependent manner (Brugge et al. 1987; Louvion et al. 1998; Xu and Lindquist 1993) , did not result in diminished growth of multiple EMC deletion strains (data not shown). This suggests that the loss of EMC-Hsp90 interaction does not globally affect the folding of Hsp90 clients. 
These experiments utilizing yeast lacking multiple components of the EMC support that there is not only a larger genetic but also a functional interaction between Hsp90 and the EMC. In order to clarify the nature of EMC-Hsp90 interaction, we looked for common genetic and physical interactors of EMCs 1-6 and Hsp90 using published data curated in BioGRID (Stark et al. 2006 ). First, we analyzed whether and what Gene Ontology biological process classifications are enriched amongst genes/proteins that interact with one or more components of the EMC. The top five statistically significant categories include transcriptional regulation, cellular transport, and cell cycle (Table 1) . When instead applying the same analysis to genes/proteins that interact with HSP82 and/or HSC82 (collectively referred to as Hsp90 interactors in this analysis), a completely different set of GO classifications is enriched, most notably ones pertaining to the ribosome and protein translation. We next focused on genes/proteins common to multiple individual components of the EMC. As shown in Table 1 , there are 23 common interactors amongst EMC2, EMC5, and EMC6, the three EMCs published to interact with Hsp90 and deleted in the NVP-sensitive strain YSL57 (Fig. 6b) . When this analysis is extended to also include interactors shared with Hsp90, the number of common interactors drops to 12; however, the most significantly enriched GO classification, protein insertion into the ER membrane, does not change. When interactions amongst EMCs 1, 2, 3, and 6 (proxy for NVP-sensitive strain YSL27) and Hsp90 are compared, nine common interactors remain. Interestingly, these nine interactors persist when EMCs 1, 2, 3, 5, and 6 (as deleted in NVP-sensitive strain YSL9) and Hsp90 are compared, as well as when all six EMCs and Hsp90 are compared, there is additionally no change in the identity of enriched GO biological process classifications from comparing only EMCs 2, 5, and 6 and Hsp90. Of note, these nine shared interactors are also the only ones common to EMCs 1-6 when compared amongst themselves 
Extension of findings to recently named members of the yeast EMC
A recently published bioinformatic analysis identified two likely additional components of the yeast EMC, EMC7 (known as SOP4) and EMC10 (YDR056C), previously thought to be conserved only in metazoans (Wideman 2015) . In order to include them in our analysis, we conducted growth assays of yeast strains individually deleted for each of the eight EMC members. Figure 8 shows that all individual deletion strains, including Δemc7/sop4 and Δemc10/ ydr056c, exhibit some sensitivity to the inclusion of NVP in the media, supporting that they, as do the previously identified EMC components, interact genetically with Hsp90.
Discussion
This study represents an effort to determine whether the occurrence of EMC2, EMC5, and EMC6 in Hsp90 interactor datasets from large-scale genetic screens is indicative of a genuine biological interaction (McClellan et al. 2007; Zhao et al. 2005) . Herein, we provide substantial experimental evidence in support of in vivo interaction between the Hsp90 chaperone machinery and the EMC. EMC2, which encodes a soluble, cytosolic component of the EMC, as well as a potential TPR domain that could indicate a means of interaction with Hsp90, was investigated first. We found that yeast with deletions of both EMC2 and the well-known Hsp90 co-chaperone STI1 exhibited increased sensitivity to the Hsp90 inhibitor NVP-AUY922, as assessed by growth on solid or in liquid media (Fig. 1) . We next utilized yeast containing various point mutant HSP82 alleles as the sole cellular source of Hsp90; these strains behaved differently when exposed to NVP, for example appearing largely unaffected by the concentrations used (T101I), exhibiting clear dosedependent growth defects (G313S), or even showing slight growth improvement (E381K; Fig. 2a, c, e) . The specific effect that EMC2 deletion had on WT and point mutant Hsp90 strains also varied significantly in liquid growth experiments in the absence or presence of NVP. If there is indeed a genuine interaction between Hsp90 and the EMC, this result is expected since each point mutation likely affects the inherent function(s) and interaction(s) of Hsp90 differently, a supposition supported by previous work utilizing these and other point mutant Hsp90 alleles in yeast (Armstrong et al. 2012 Same as a, except plates were incubated at 37°C for 2 days (DMSO) or 3 days (75 μM NVP). al. 1998; Flom et al. 2012; Johnson et al. 2007; Louvion et al. 1998 ). Further genetic evidence of an interaction is provided by experiments in which established Hsp90 cochaperones are overexpressed in WT HSP82 yeast (Fig. 3) or point mutant hsp82 yeast (Fig. 4) that contain or lack EMC2. Most notably, the ability of Sti1p to improve the growth of strains on media containing NVP is abolished when EMC2 is deleted. The additional observation that TAH1 overexpression could rescue the Hsp90 inhibitor sensitivity of yeast whether or not EMC2 was present suggests that while some cellular functions of Hsp90 involve EMC2, others do not. Sti1p localizes primarily to the cytoplasm and has the ability to bind simultaneously to both Hsp70 and Hsp90, thus facilitating the delivery of a subset of client proteins to Hsp90. Tah1, on the other hand, serves to bridge Hsp90 to the larger R2TP complex (Kakihara and Houry 2012) , which is implicated in the assembly of complexes in the nucleus (snoRNP biogenesis, for example) and the cytosolic assembly of complexes that are important for functions in the nucleus (i.e., RNA polymerase II). Perhaps Sti1p additionally functions with Hsp90 in secretory pathway-related activities (discussed below), and it is those activities that are also EMC-dependent but do not require Tah1p. Altogether, these experiments establish a robust genetic interaction between Hsp90 and EMC2. This relationship extends to a physical interaction as well (Fig. 5) , although the precise region of Emc2p that facilitates interaction with Hsp90, as well as whether binding is direct or indirect, remains unknown. The finding that deletion of amino acids critical for predicted TPR domain formation does not affect the ability of Emc2p to bind Hsp90 does not necessarily mean that it is not acting as a co-chaperone; there are both numerous examples of Hsp90 cochaperones that lack TPR domains as well as at least one example of an Hsp90 co-chaperone that has a TPR domain but does not use it for interaction with Hsp90 (Lee et al. 2004) . As the latter case suggests that the TPR domain may instead be used to bridge the binding of Hsp90 to other proteins, such as in the context of a multi-protein complex, we next extended our analysis to include the larger EMC. Yeast lacking multiple components of the EMC exhibit increased sensitivity to Hsp90 inhibitor in growth assays (Fig. 6 ) and, interestingly, display a lack of glucocorticoid receptor folding (Fig. 7) . Collectively, our experimental evidence supports a genetic, physical, and functional interaction of the Hsp90 chaperone machinery and the EMC.
Gene Ontology analysis of published interactions ascribed to either Hsp90 or combined individual EMC components yields distinct results; the top five most significantly enriched GO biological process assignments for each have none in common (Table 1) . When instead comparing only interactors shared amongst EMCs 1-6, the results are no different when Hsp90 interactors are also included. Thus, the only published interactors shared amongst EMCs 1-6 are also published Hsp90 interactors, suggesting that the enriched GO categories may represent the cellular processes in which Hsp90 and the EMC interact. It is therefore worth noting that the top significantly enriched category is that of Bprotein insertion into the ER membrane,^which has been recently described as a function of the EMC in mammalian cells (Guna et al. 2018) .
There is currently only indirect evidence that Hsp90 has some role to play in this process. Yeast with deletions of each of the five members of the Bguided entry of tailanchored proteins^complex (Jonikas et al. 2009; Schuldiner et al. 2008) , GET1, GET2, GET3, GET4, and GET5 (aka MDY2), exhibit synthetic growth defects in combination either with chemical inhibition of Hsp90 or with a temperature-sensitive point mutant allele of Hsp90, hsp82 G170D (McClellan et al. 2007; Nathan and Lindquist 1995; Zhao et al. 2005) . The requisite GET pathway co- Glucocorticoid activity is compromised in yeast lacking multiple EMC components. Mid-log phase cultures of the indicated yeast strains, all constitutively expressing glucocorticoid receptor (GR) and bearing a glucocorticoid response element (GRE) upstream of the betagalactosidase gene, were grown in the absence (−) or presence (+) of steroid hormone (10 μM deoxycorticosterone, DOC) at 30°C for 1 h. Subsequent cell extracts were subjected to beta-galactosidase activity assays and arbitrary units of activity calculated (see BMaterials and methods^). Data represent the mean ± standard deviation from a minimum of four experimental replicates. Highly statistically significant differences as determined by Student's t test are indicated with brackets and single (*p < 0.01) or double (**p < 0.001) asterisks (differences for Δsti1 were also p < 0.001, brackets not shown). YSL4 = Δemc1 Δemc5, YSL5 = Δemc3 Δemc6, YSL6 = Δemc1 Δemc2 Δemc5, YSL9 = Δemc1 Δemc2 Δemc3 Δemc5, YSL27 = Δemc1 Δemc2 Δemc3 Δemc6, YSL57 = Δemc2 Δemc5 Δemc6 chaperone SGT2, which contains a TPR motif, also has reported interactions with Hsp90 (Chartron et al. 2011; Franzosa et al. 2011; Krysztofinska et al. 2017; Liou et al. 2007; McClellan et al. 2007; Wang et al. 2010) . Additionally, there are numerous established interactions between EMC components and members of the GET pathway (Costanzo et al. 2010; Costanzo et al. 2016; Hoppins et al. 2011; Jonikas et al. 2009; Pan et al. 2006; Schuldiner et al. 2005; Schuldiner et al. 2008; Surma et al. 2013 ). These interaction-based speculations aside, Hsp90 has been suggested previously to assist both the trafficking and membrane insertion of v-src (Xu and Lindquist 1993) , Hsp90 inhibition diminished the ability of the Rab-specific GDP dissociation inhibitor (αGDI) to extract Rab3a from synaptic membranes (Sakisaka et al. 2002) , and Hsp90 collaborates with rab11 in the membrane insertion and/or retrieval of α-synuclein (Liu et al. 2009 ); thus, a role for Hsp90 in facilitating protein insertion into cellular membranes is not without precedent.
Recent work in mammalian cells suggests that while the GET complex is more suited for handling target proteins with highly hydrophobic transmembrane domains, the EMC instead assists proteins whose less hydrophobic tails are shielded by calmodulin prior to ER membrane insertion (Guna et al. 2018) . It is interesting to note that there are reported interactions in yeast of calmodulin with both Hsp90 and GET2, but not with the EMC (Costanzo et al. 2016) . In yeast, the GET pathway definitively interacts with the tail-anchored protein Sec22p, which has a transmembrane helix hydrophobicity of~87% (Wang et al. 2010) . SEC22 also has reported interactions with both the EMC and Hsp90 (Costanzo et al. 2016; Jonikas et al. 2009; Zhao et al. 2005) , raising the possibility that Hsp90 may facilitate triage of ER-destined tail-anchored membrane proteins to one, the other, or both pathways. This could perhaps be managed in conjunction with other cellular chaperones and co-chaperones that act upstream of Hsp90; intriguingly, there are numerous examples of such that are known interactors of only Hsp90 and GET pathway members (Ssa1/2, Sse1/2, Hsp104, Hsp42, Sis1, Scj1, Ydj1, She4, and Cdc37), and of only Hsp90 and EMC components (Hsp31, Caj1, and Hlj1), or that interact with all three systems (Ssb2, Ssc1, Lhs1, Cpr7, and Cdc48; for interaction references, see https://www.thebiogrid.org). Some of these proteins are themselves tail-anchored ER membrane proteins, for example Hlj1 (Beilharz et al. 2003) , and could instead (or additionally) represent targets of a proposed Hsp90/EMC sorting pathway; of note, the membrane domain of Hlj1 has a hydrophobicity of only~71%, within the established range of proteins expected to transit via the EMC (transmembrane domain hydrophobicity < 72%) versus the GET complex (transmembrane domain hydrophobicity > 73%) (Guna et al. 2018) . Taken all together, it seems that it would be worthwhile to directly investigate a possible role for Hsp90 in ER membrane protein targeting or insertion. A remaining possibility is that the substantial connections between Hsp90, the EMC, and the GET complex are instead, perhaps, the consequence of Hsp90's participation in the assembly or maintenance of cellular protein complexes. The results of large-scale Hsp90 target screens have a demonstrated enrichment for highly interactive network hubs, which may reflect the significant presence of members of multi-protein complexes in these datasets (McClellan 2007; Gopinath 2014) . Most notable, perhaps, is the enrichment of secretory pathway complex components including two or more members of the COG, AP-1, AP-3, TRAPP, ESCRT I, ESCRT II, ESCRT III, COPI, and Retromer complexes (McClellan 2007) . The EMC would also have been included in these findings but had not yet been identified at that time. It is perhaps worth speculating that the essential function of Hsp90 in eukaryotic cells has to do with the pleiotropic functions of Hsp90 in the assembly, disassembly, or maintenance of the multitude of protein complexes throughout the endomembrane system. Hsp90 has roles in other critical cellular functions; for example, it has demonstrated ribosomal interactions in both eukaryotes and prokaryotes but yet is not essential for viability in the latter (Babu et al. 2014; Butland et al. 2005; Franzosa et al. 2011; Kim et al. 2006; Tenge et al. 2015) . That Hsp90 essentiality may have co-evolved with the endomembrane system, and multicellular eukaryotes, aligns well with the presence, and essential nature, of only cytosolic Hsp90 in the single-celled eukaryote Saccharomyces cerevisiae and the subsequent arisal of compartment-specific Hsp90s in higher eukaryotes, which are found in the mitochondria, the endoplasmic reticulum, and even the extracellular matrix.
Overall, our results support that Hsp90 and the EMC interact, consistent with a possible role for Hsp90 in either independently assisting the conformational maintenance/assembly of the EMC, and other protein complexes involved in protein targeting and trafficking, or in playing an important role in assisting or determining the pathway that a protein destined for a certain fate, such as membrane insertion, may take. One could envision both the former and the latter being facilitated by interactions with specific co-chaperones that direct Hsp90 or its clients to alternate paths. Miller for their helpful suggestions and discussions throughout this work and Lars Ellgaard for critical reading of the manuscript.
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